AU2001290678A1 - Alginate particle formulation - Google Patents

Alginate particle formulation

Info

Publication number
AU2001290678A1
AU2001290678A1 AU2001290678A AU9067801A AU2001290678A1 AU 2001290678 A1 AU2001290678 A1 AU 2001290678A1 AU 2001290678 A AU2001290678 A AU 2001290678A AU 9067801 A AU9067801 A AU 9067801A AU 2001290678 A1 AU2001290678 A1 AU 2001290678A1
Authority
AU
Australia
Prior art keywords
particle formulation
alginate particle
alginate
formulation
particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290678A
Inventor
Frank Kochinke
Sung-Yun Kwon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Research Ltd
Original Assignee
Powderject Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Research Ltd filed Critical Powderject Research Ltd
Publication of AU2001290678A1 publication Critical patent/AU2001290678A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001290678A 2000-09-08 2001-09-07 Alginate particle formulation Abandoned AU2001290678A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23111900P 2000-09-08 2000-09-08
US60/231,119 2000-09-08
PCT/US2001/028142 WO2002019989A2 (en) 2000-09-08 2001-09-07 Alginate particle formulation

Publications (1)

Publication Number Publication Date
AU2001290678A1 true AU2001290678A1 (en) 2002-03-22

Family

ID=22867804

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290678A Abandoned AU2001290678A1 (en) 2000-09-08 2001-09-07 Alginate particle formulation

Country Status (3)

Country Link
US (1) US20020051821A1 (en)
AU (1) AU2001290678A1 (en)
WO (1) WO2002019989A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040014698A1 (en) * 2002-07-18 2004-01-22 Gonzalo Hortelano Oral administration of therapeutic agent coupled to transporting agent
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20060286141A1 (en) * 2003-12-15 2006-12-21 Campbell Todd D Systems for gel-based medical implants
JP2010505883A (en) 2006-10-12 2010-02-25 ザ ユニバーシティー オブ クイーンズランド Compositions and methods for modulating immune responses
EP2155274A4 (en) * 2007-06-13 2012-11-28 Fmc Corp Implantable degradable biopolymer fiber devices
WO2009067621A1 (en) 2007-11-21 2009-05-28 Decode Genetics Ehf Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
WO2010059836A1 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
US8673931B2 (en) 2009-01-26 2014-03-18 Abraham Fisher Bicyclic heterocyclic spiro compounds
DK2635596T3 (en) 2010-11-01 2019-11-25 Univ Sydney Technology IMMUN MODULATORS AND USES THEREOF
US9205150B2 (en) 2011-12-05 2015-12-08 Incept, Llc Medical organogel processes and compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204111A (en) * 1989-04-07 1993-04-20 L'oreal Process for the preparation of alginate capsules, apparatus for producing said capsules and cosmetic compositions containing said capsules
EP0454044B1 (en) * 1990-04-25 1995-12-06 Hoechst Aktiengesellschaft Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
TW404844B (en) * 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
US5899880A (en) * 1994-04-08 1999-05-04 Powderject Research Limited Needleless syringe using supersonic gas flow for particle delivery
GB9514285D0 (en) * 1995-07-13 1995-09-13 Univ Nottingham Polymeric lamellar substrate particles for drug delivery
US6013050A (en) * 1995-10-20 2000-01-11 Powderject Research Limited Particle delivery
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
WO1998035666A1 (en) * 1997-02-13 1998-08-20 Nanosystems Llc Formulations of nanoparticle naproxen tablets
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles
WO2000045792A1 (en) * 1999-02-03 2000-08-10 Powderject Research Limited Hydrogel particle formulations

Also Published As

Publication number Publication date
WO2002019989A2 (en) 2002-03-14
WO2002019989A3 (en) 2002-08-15
US20020051821A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
AU1995800A (en) Particle manipulation
AU7429100A (en) Chondrocyte compositions, preparation and use thereof
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AUPQ419099A0 (en) Novel compositions and methods
AU2002212254A1 (en) Microcapsule powder
AU2001258801A1 (en) Gelling composition
AU2001295657A1 (en) Formulation containing wax-esters
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001291547A1 (en) Particle concentrator
AU2184099A (en) Insecticidal compositions and insecticidal methods
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2001290678A1 (en) Alginate particle formulation
AU2001283862A1 (en) Bvdv virus-like particles
AU1152601A (en) Compositions and their use
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2002229654A1 (en) Nanoparticle-containing peeling compositions
AU2002346252A1 (en) Particle probe
AU1533801A (en) Particle size distribution analyser
AUPR099200A0 (en) New formulation
AU5931300A (en) Ringene compositions and methods for use thereof
AU2002359869A1 (en) Pak5-related compositions and methods
AU1275001A (en) Solid particles
AU6042601A (en) Compounds and their uses
AU3347300A (en) Desmethylsildenafil compositions and methods